Identification of a new series of non-peptidic NK3 receptor antagonists
摘要:
The identification and structure-activity relationships of 2-aminomethyl-1-aryl cyclopropane carboxamides as novel NK3 receptor antagonists are reported. The compound series was optimized to give analogues with low nanomolar binding to the NK3 receptor and brain exposure, leading to activity in vivo in the senktide-induced hypoactivity model in gerbils. (C) 2011 Elsevier Ltd. All rights reserved.
Cyclopropyl derivatives as nk3 receptor antagonists
申请人:Kehler Jan
公开号:US20060281746A1
公开(公告)日:2006-12-14
The present invention relates to cyclopropyl derivatives of formula (I) and salt thereof. These compounds are NK3 receptor antagonists and may therefore be useful for treatment of diseases where the NK3 receptor is implicated, e.g. psychotic disorders.
Cyclopropyl derivatives as NK3 receptor antagonists
申请人:H. Lundbeck A/S
公开号:US07834008B2
公开(公告)日:2010-11-16
The present invention relates to cyclopropyl derivatives of formula (I) and salt thereof. These compounds are NK3 receptor antagonists and may therefore be useful for treatment of diseases where the NK3 receptor is implicated, e.g. psychotic disorders.
CYCLOPROPYL DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS
申请人:H. LUNDBECK A/S
公开号:EP1656349A1
公开(公告)日:2006-05-17
US7834008B2
申请人:——
公开号:US7834008B2
公开(公告)日:2010-11-16
[EN] CYCLOPROPYL DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS<br/>[FR] DERIVES DE CYCLOPROPYLE UTILISES COMME ANTAGONISTES DU RECEPTEUR DE NK3
申请人:LUNDBECK & CO AS H
公开号:WO2005016884A1
公开(公告)日:2005-02-24
The present invention relates to cyclopropyl derivatives of formula (I) and salt thereof. These compounds are NK3 receptor antagonists and may therefore be useful for treatment of diseases where the NK3 receptor is implicated, e.g. psychotic disorders.